Showing 2,671 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C symptoms & diagnosis

Study: Door-to-door campaign linked hepatitis C patients to care

Editor's pick
Eurekalert Inf Dis
16 February 2015
Pharmaceutical industry

Healthcare: The race to cure rising drug costs

Editor's pick
Financial Times
13 February 2015
New & experimental hepatitis C treatment

Health News Review analysis of Reuters' coverage of new hepatitis C drugs

Editor's pick
Health News Review
13 February 2015
Access to healthcare

UNITAID: 2015 Hepatitis C medicines technology and market landscape

Editor's pick
UNITAID
13 February 2015
Hepatitis C treatment

Gilead agrees 41,000 euro hep-C drug price for 12 week treatment in Germany

Editor's pick
Reuters
13 February 2015
Hepatitis C treatment

Gilead expects big increase in Europeans treated with hep C drug

Editor's pick
Reuters
11 February 2015
New & experimental hepatitis C treatment

FDA revokes breakthrough status for BMS hep C drug

Editor's pick
Fierce Biotech
11 February 2015
New & experimental hepatitis C treatment

Regulus Therapeutics reports top-line results from RG-101 clinical study for HCV treatment

Editor's pick
Regulus Therapeutics press release
11 February 2015
Hepatitis C symptoms & diagnosis

Strategies for Slowing the Progression of Liver Fibrosis in Hepatitis C

Editor's pick
HCP Live
11 February 2015
HIV treatment

CROI 2015 Preview: New Research on HIV, Hepatitis C and Ebola

Editor's pick
The Body Pro
11 February 2015
Hepatitis C treatment

A more personalised approach to hepatitis C treatment may improve adherence and completion rates

News
11 February 2015
Access to healthcare

Gilead faces challenge to European patent on pricey hep C drug

Editor's pick
Reuters
10 February 2015
New & experimental hepatitis C treatment

Promising data bodes well for all-Achillion hep C treatment

Editor's pick
Reuters
10 February 2015
New & experimental hepatitis C treatment

Achillion Achieves 100% SVR12 in Phase 2 Trial Evaluating 6-Week Combination Treatment With ACH-3102

Editor's pick
Achillion press release
9 February 2015
Hepatitis C treatment

Worldwide treatment of hepatitis C could be within sight at the right cost

Editor's pick
Imperial College press release
9 February 2015
Finance & funding

Obama Budget Boosts U.S. HIV and Hepatitis Funding, Cuts Global AIDS and TB

Editor's pick
HIVandHepatitis.com
9 February 2015
Access to healthcare

Portugal agrees to treat 13,000 hepatitis C patients

Editor's pick
Xinhua
9 February 2015
Hepatitis C treatment

What the 'Shocking' Gilead Discounts on its Hepatitis C Drugs Will Mean

Editor's pick
Wall Street Journal (blog)
5 February 2015
Hepatitis C treatment

Sales of Sovaldi, New Gilead Hepatitis C Drug, Soar to $10.3 Billion

Editor's pick
New York Times
5 February 2015
Hepatitis B

Hepatitis Quest Moves From C to B Under Former Gilead Executives

Editor's pick
Bloomberg
5 February 2015
Hepatitis C transmission & prevention

Hepatitis C more prevalent than HIV/AIDS or Ebola yet lacks equal attention

Editor's pick
Medical Xpress
5 February 2015
New & experimental hepatitis C treatment

Merck says hepatitis C drugs to lose breakthrough status

Editor's pick
Reuters
5 February 2015
Finance & funding

How Hepatitis C Is Shining A Light On Critical Gaps In Payment Reform

Editor's pick
Health Affairs (blog)
4 February 2015
Hepatitis C transmission & prevention

ChemSex and HCV transmission among UK MSM

Editor's pick
BMJ Group blogs
3 February 2015